Balyasny Asset Management
HIMS icon

Balyasny Asset Management’s Hims & Hers Health HIMS Stock Holding History

Balyasny Asset Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.57M Buy
123,600
+43,600
+55% +$1.03M ﹤0.01% 1677
2025
Q4 		$2.6M Sell
80,000
-13,400
-14% -$574K ﹤0.01% 1738
2025
Q3 		$5.3M Buy
93,400
+29,800
+47% +$1.53M 0.01% 1346
2025
Q2 		$3.17M Buy
63,600
+21,800
+52% +$985K ﹤0.01% 1512
2025
Q1 		$1.24M Buy
+41,800
New +$1.55M ﹤0.01% 1909
2023
Q2 		– Sell
-650,000
Closed -$6.45M – 2489
2023
Q1 		$6.45M Buy
+650,000
New +$5.7M 0.02% 974

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DE
Defiance ETFs New York $6.98B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Balyasny Asset Management's HIMS Position: Q2 2025 in Review

Balyasny Asset Management sold out of Hims & Hers Health (HIMS) in Q2 2025, closing a stake of 53,796 shares — an estimated $2.43M sold.

Balyasny Asset Management first reported a position in HIMS in Q1 2021 and held it in 8 quarters. The position peaked at $31.3M in Q3 2024. 510 funds tracked by Wall St. Rank hold HIMS as of Q2 2025.

  • Balyasny Asset Management reported no remaining Hims & Hers Health position as of Q2 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 53,796 Hims & Hers Health shares in Q2 2025, an estimated $2.43M.
  • Balyasny Asset Management first reported a position in Hims & Hers Health in Q1 2021 and held it in 8 quarters.
  • Balyasny Asset Management's Hims & Hers Health position peaked at $31.3M in Q3 2024.
  • 510 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2025.

Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.